{
  "id": "adv_mhgap#risk_safety_581b0b30",
  "content": "y Service providers should assess psychosocial\nwas no evidence of an association between\nstressors (e.g. domestic abuse, unemployment)\nbaseline severity and the network estimates in\nassociated with depression and include appropriate\nmeta-regression analysis.\npsychosocial interventions in their treatment plan.\ny TCAs are generally less well tolerated than SSRIs\ny Providers should keep in mind the possible adverse\nand are also generally considered less safe, due to\neffects associated with antidepressants, the ability\nanticholinergic side-effects, toxicity, psychomotor\nto deliver either intervention (in terms of expertise\nand cognitive impairment risks, and lethality risks\nand/or treatment availability) and individual\nin cases of acute intoxication or overdose. TCAs\npreferences. Discontinuities in drug availability\nare therefore recommended for consideration in\n58\n3. Recommendations\n(common in LMICs) may interfere with continuation characteristics (e.g. higher risks and side-effects\nof treatment. that may be associated with pregnancy or older\ny Generic TCAs and many generic SSRIs are associated age), side-effects profiles (e.g. sexual dysfunction,\nwith low acquisition costs. Cost of daily dose of sleep problems, weight gain) and availability (e.g.\ngeneric antidepressants varies from region to region continuous availability, costs).\nthroughout the world ranging between 3% and 9% y Explain rationale for prescribing and provide written",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "stress",
      "work",
      "risk_safety",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Risk Safety y Service providers should assess psychosocial\nwas no evidence of an association between\nstressors (e.g. domestic abuse, unemployment)\nbaseline severity and the network estimates in\nassociated with depression and include appropriate\nmeta-regression analysis.\npsychosocial interventions in their treatment plan.\ny TCAs are generally less well tolerated than SSRIs\ny Providers should keep in mind the possible adverse\nand are also generally considered less safe, due to\neffects associated with antidepressants, the ability\nanticholinergic side-effects, toxicity, psychomotor\nto deliver either intervention (in terms of expertise\nand cognitive impairment risks, and lethality risks\nand/or treatment availability) and individual\nin cases of acute intoxication or overdose. TCAs\npreferences. Discontinuities in drug availability\nare therefore recommended for consideration in\n58\n3. Recommendations\n(common in LMICs) may interfere with continuation characteristics (e.g. higher risks and side-effects\nof treatment. that may be associated with pregnancy or older\ny Generic TCAs and many generic SSRIs are associated age), side-effects profiles (e.g. sexual dysfunction,\nwith low acquisition costs. Cost of daily dose of sleep problems, weight gain) and availability (e.g.\ngeneric antidepressants varies from region to region continuous availability, costs).\nthroughout the world ranging between 3% and 9% y Explain rationale for prescribing and provide written Y service providers should assess psychosocial\nwas no evidence of an association between\nstressors (e.g. domestic abuse, unemployment)\nbaseline severity and the network estimates in\nassociated with trầm cảm and include a..."
}